Extended Data Fig. 3: PD-1/CTLA-4 receptor occupancy (RO) following multiple doses of cadonilimab in combination with chemotherapy. | Nature Medicine

Extended Data Fig. 3: PD-1/CTLA-4 receptor occupancy (RO) following multiple doses of cadonilimab in combination with chemotherapy.

From: Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial

Extended Data Fig. 3

Visit days were presented on the X axis, percent RO on the Y axis; Plot points were observed data. The boxplots represented median (bold line) and 25th and 75th percentiles of RO distribution. All visits were predose, except for C1D8. 1 cycle = 2 weeks for Q2W or 1 cycle = 3 weeks for Q3W.

Back to article page